Japan, May 13 -- ANTLERA THERAPEUTICS INC has got intellectual property rights for 'FRIZZLED RECEPTOR ANTIBODIES AND USES THEREOF.' Other related details are as follows:

Application Number: JP,2024-118341

Category (FI): A61K47/68,A61P35/00,A61P1/04,A61K45/00,A61K39/395@L,A61P11/00,A61P1/16,A61P15/00,C07K16/28,A61K35/12,A61K35/54,A61P43/00,105,A61P1/18,A61P1/02,C12N15/62@Z,C07K16/46,A61P13/12,A61K39/395@N,C12Q1/02,A61P13/10,C12P21/08,C12N15/13,C12N5/10,C12N1/21,C12N1/19,A61P25/00,C12N1/15,A61P13/08,G01N33/531@A,G01N33/53@D,A61P35/02,A61P19/08,A61K48/00

Stage: Grant (IP right granted following substantive examination.)

Filing Date: July 24, 2024

Publication Date: Oct. 29, 2024

The original document can be viewed at: https://www.j-platpa...